(1)
LOW-DOSE VERSUS STANDARD-DOSE RITUXIMAB IN VESICULOBULLOUS DISORDERS: A COMPARATIVE EFFECTIVENESS STUDY. A-JMRHS 2026, 4 (2), 1638-1642. https://doi.org/10.65605/a-jmrhs.2026.v04.i02.pp1638-1642.